Wird geladen...
Phase II Trial of Angiotensin-(1-7) for the Treatment of Patients with Metastatic Sarcoma
Background. Angiotensin-(1-7) [Ang-(1-7)] is an endogenous antiangiogenic hormone with anticancer activity. In a phase I study of Ang-(1-7), two of three patients with metastatic sarcoma experienced disease stabilization. This phase II study examined clinical and biomarker outcomes for patients with...
Gespeichert in:
| Veröffentlicht in: | Sarcoma |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Hindawi Publishing Corporation
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5118533/ https://ncbi.nlm.nih.gov/pubmed/27895527 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/4592768 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|